Clinical trial
Safety Study of Sodium Divalproate in Bipolar Disorder in Adolescents
NCT00271258 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00271258 |
|---|---|
| Title | Safety Study of Sodium Divalproate in Bipolar Disorder in Adolescents |
| Official title | STUDY OF THE TOLERANCE OF SODIUM DIVALPROATE (DEPAKOTE) IN ADOLESCENTS IN MANIC, MIXED OR HYPOMANIC EPISODES OF BIPOLAR DISORDER |
| Acronym | ADOKOT |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | SODIUM DIVALPROATE |
| Enrollment | 200 |
| Start date | Jan 1, 2005 |
| Completion | Jan 1, 2007 |
| First posted | Dec 30, 2005 |
| Last update posted | Jan 11, 2011 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: